More Vaccine News: GSK Talks HSV-2 glycoprotein-D  

rm_Pebcac80 42M
104 posts
6/23/2006 7:49 am
More Vaccine News: GSK Talks HSV-2 glycoprotein-D

GlaxoSmithKline has been going through a new test on the HSV-2 glycoprotein-DĀ­subunit vaccine, and began a new series in 2005. While the drug does not make a difference in those in those who are current carries of HSV1 or HSV2, for those of us who are not carries of HSV1 or HSV2, the vaccine may be a significant start in making progress toward eliminating the spread of HSV.

Prior tests done on Subunit vaccines (1999, 2002) where seen to be of "some" effectiveness, but did not match the threshhold (about 80-90% effective) that many look for. Since I can't seemingly post links, I will say: AHM and Science are reporting that early results from the new sets of clinical trials are providing solid results that indicate the newer revisions of Dsubunit vaccines have a significantly higher rate of success then previous versions and that there is some reason to be hopeful of a preventive vaccine within the next five-ten years.

There will be those who object to the development of such vaccines. But science has to progress. The research study is still ongoing, but news of it, reported this morning via MSNBC, will also be reported in Time and others soon. Is there a "debate"? I'm sure there is. But for those of us who do not carry HSV, what is the reason to root "against" finding a vaccine? And for those who are young, who are the key target group of the vaccine (age 12-17) I would view it the same way I would the chickenpox vaccine - which was a first step to making this kind of research happen. Anything that can save you some trauma is a good thing.

Become a member to create a blog